SERVICES
As your Contract Research Organization, at OXON we plan and implement the generation of Real-World patient centred evidence
KNOW MORESTUDIES
We help you to effectively meet the requirements of late-phase clinical studies for better outcomes or greater value
KNOW MORETHERAPEUTIC AREAS
OXON offers proven trial experience and a portfolio of completed studies and publications in a broad range of therapeutic areas
KNOW MOREA few things we’re great at
OXON has been selected as a preferred provider by several big pharma companies.
READ ABOUT USWe strive our best to support our clients in conducting cost-efficient observational studies worldwide
We pulled together
professionals and resources to serve you better
READ MOREOXON: YOUR OBSERVATIONAL STUDIES SERVICE PROVIDER
Let us help design and conduct your optimal PASS or Outcomes observational study
OXON epidemiologists, statisticians, clinicians and project managers (ex-big pharma, ex-EMA), supported by consultancy from Stuart Pocock, Professor of Medical Statistics, London School of Hygiene & Tropical Medicine (´Pocock Stopping Rule´, sat on many data monitoring committees, extensive experience with EMA and FDA, classic textbook ´Clinical Trials´, 30+ NEJMs and 40+ Lancets)
REQUEST A MEETINGNewsroom
Read about us, our latest news and events
RWE & Trials Live Masterclass Session 2: “The Tyranny of Propensity Scores”
“The Tyranny of Propensity Scores” will be the main topic of the next session of our RWE & Trials Masterclass Series Propensity Scores will be the main topic of the[…]
Read more
OXON’s Real-World Evidence & Trials Free Live Masterclass Series 2021
Real-World Evidence & Trials Masterclass Series 2021 OXON Epidemiology will be hosting a Real-World Evidence Masterclass Series for all professionals interested in learning about the role of Real-World Data studies[…]
Read more
OXON wins first prize for a spotlight poster at ICPE20 All Access Virtual Conference
OXON is delighted to be supporting ICPE again this year with a virtual exhibition booth from which we will be happy to speak with you about our specialisation in data collection, secondary data and hybrid real world studies, pragmatic trials and meta-analyses to help plan, design and implement RWE for safety, market access and drug development.
Read more